You are here

Coagulation Sciences, LLC

The MCTS system enables caregivers to perform point-of-care analyses in bleeding patients and determine causes of bleeding to aide in treatment decisions

Details

Founded: 2002
Employees: 2
Quick Pitch:

Overview

Coagulation Sciences is a blood-testing innovator that has developed a Transfusion Management System to scientifically manage blood transfusions at the patient’s point-of-care. Coagulation Sciences’ system will improve outcome for patients who are bleeding, while simultaneously reducing healthcare costs.

Management

President

Sheldon Goldstein

Dr. Goldstein is the inventor of the MCTS™ device and the visionary behind the Company’s blood transfusion related Intellectual Property. Dr. Goldstein is an Internist & Cardiac Anesthesiologist practicing at New Jersey Medical School, having received his medical degree at Hahnemann Medical College in Philadelphia (renamed Drexel/Hahnemann). Dr. Goldstein is an expert in the management of bleeding patients, and has been invited to speak on coa

Dir of Product Development

Michael Todd Kagan

Mr. Kagan leads the development process for the Company’s devices, from prototyping and testing to manufacturing transfer and commercialization. Mr. Kagan brings 28 years of successful experience in the diagnostics industry, having worked at Immunicon, Chiron, and Ciba Corning, where he led engineering and manufacturing initiatives that resulted in FDA clearances for six in-vitro medical devices, and the associated test kits.

Chairman

Lee Golden

Dr. Golden, Chief Medical Officer at Gemphire Therapeutics (Nasdaq:GEMP), has held senior leadership positions at Mesoblast, Novartis, Eisai Medical Research and Pfizer Pharmaceuticals. He is a graduate of New York University School of Medicine and is trained as an Interventional Cardiologist.

Jobs

Know of jobs at this company? List them!

Submit a new job now